CTOs on the Move

New York Blood Center

www.ccmail.org

 
New York Blood Center is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $250-500 Million
  • www.ccmail.org
  • 150 Amsterdam Ave
    New York, NY USA 10023
  • Phone: 212.468.2150

Executives

Name Title Contact Details

Similar Companies

AART

AART is a Reno, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

D.M.I. Medical

D.M.I. Medical is a Hollywood, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sequana Medical

Sequana Medical is a Saratoga, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accelerate Diagnostics

Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The companys revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the Accelerate ID/AST System development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.

SteadyMed

SteadyMed Therapeutics, Inc. is a Specialty Pharmaceutical Company. SteadyMed leverages its PatchPump platform to develop its own therapeutic portfolio and partners to optimize the delivery of high volume (greater than two mL), high value, small molecule or biologic drugs. Our family of PatchPumps can be customized to deliver liquid drugs, including biologics, with a wide range of volumes and viscosities, in a consistent and controllable manner. SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications: Extending the limits of parenteral therapeutics to restore freedom, joy and dignity to patients’ lives.